{"id":"NCT02773849","sponsor":"Ferring Pharmaceuticals","briefTitle":"ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)","officialTitle":"A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRINÂ® (rAd-IFN)/Syn3) Administered Intravesically to Patients With High-Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-19","primaryCompletion":"2019-05-24","completion":"2023-05-24","firstPosted":"2016-05-16","resultsPosted":"2022-07-13","lastUpdate":"2024-07-29"},"enrollment":157,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Superficial Bladder Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"ADSTILADRIN","otherNames":["rAd-IFN/SYN3NODA","INSTILADRIN"]}],"arms":[{"label":"ADSTILADRIN","type":"EXPERIMENTAL"}],"summary":"Previous multi-dose Phase I and Phase II clinical studies have demonstrated that ADSTILADRIN is a safe and effective treatment for BCG-refractory and recurrent NMIBC. This Phase III study is designed to expand those observations using a high dose of ADSTILADRIN in patients that are \"BCG Unresponsive\" which refers to patients with high-grade NMIBC who are unlikely to benefit from and should not receive further intravesical BCG.","primaryOutcome":{"measure":"Number of Patients With a Complete Response Rate Based on Patients With Carcinoma in Situ (CIS), With or Without Concomitant High-grade Ta or T1 Papillary Disease.","timeFrame":"12 Months","effectByArm":[{"arm":"Carcinoma in Situ","deltaMin":55,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":34,"countries":["United States"]},"refs":{"pmids":["33253641","40194933"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":107},"commonTop":["Instillation site discharge","Fatigue","Bladder spasm","Micturition urgency","Haematuria"]}}